Topical Ivermectin

Rosacea and Sklice

Sklice is a new topical ivermectin 0.5% that is approved for the use of the scalp and hair for head lice.

Rosacea Support Links

 

• Tips for Getting Started
• Why, Oh Why Did I Get Rosacea?
• Frequently Asked Questions
• Just Diagnosed with Rosacea
• Top 5 Cheapest Rosacea Treatments
• The one thing I wish I was told about Treating Rosacea
• The BEST Treatment for Rosacea
• Treating Ocular Rosacea
• Official Rosacea Treatments
• Rosacea Treatments for Each Symptom

Rosacea News June 2012

1. Treating Rosacea with Collagen (Matricol)

Martricol, which is freeze dried sheets of collagen, is another example of a hopeful rosacea treatment emerging in a patent application. This time a health care company in …

2. “MetroFoam” is Better than Metrogel

OK the title is a bit of a stretch as currently there is no such product as Metrofoam, but keep reading to see where I’m coming from. Last year a patent surfaced, owned by Galderma, claiming rights to a “stable, metronidazole-based oil-in-water emulsion expandable into a topically applicable foam having a firm, creamy and light consistency” and is claimed to have improved release-penetration …

3. Demodex Bacteria Protein Response Isolated

Hot on the heels of a paper detailing the fact that demodex bacteria-based proteins inhibit corneal wound recovery, is this paper consolidating a direct relationship between an immune response and facial and ocular rosacea.

Recent research from 2007 has isolated 2 proteins from the bacteria from Bacillus oleronius, that …

4. Counting Demodex Mites with a Confocal Laser Microscope

This paper describes a new way of counting facial demodex mites. A type of microscope called a Confocal Laser Scanning Microscope was used to look for `roundish or lengthy cone-shaped structures’ on the skin, and these were …

5. Tanda Luxe (Red LEDs) for Facial Wrinkles and Cheek Rosacea

A clinical trial has been listed for the Tanda Luxe, a Red LED device that is to be used as a treatment for wrinkles and facial rosacea, especially on …

6. Wanted SF: Daily SPF15 Green Tint Corrector Trialists

I have been contacted by Yvonne Law from Biometrix, who are looking for volunteers in San Francisco who are interesting in trialing a new product from a well known cosmetic company. The product is a “facial SPF with green tint corrector to reduce facial redness”. The company says that this product is “now being researched for efficacy, safety in use, and advertising claim support." …

7. Allergan Developing Oxymetazoline (AGN-199201/V-101) Cream Formulations

A recently surfaced patent application shows that Allergan are continuing to protect their intellectual property around their proposed Oxymetazoline based facial redness treatment.

This patent application relates to the technology and inventions used to create a suitable cream formulation of oxymetazoline. It covers how …

8. Xeomin (Botulinum Toxin Type A) being Trialled as a Rosacea Treatment

The BOTOX relative Xeomin is to be trialled as a treatment on the cheeks of rosacea sufferers. We are not told in the trial description if the rosacea …

9. Elevated Proteins in The Skin of Ocular Rosacea Sufferers

The following abstract details some research that was undertake to characterise what is happening in ocular rosacea. There is currently no accepted diagnostic test for rosacea. Some History Rosacea News first highlighted a possible diagnostic test for ocular rosacea in late 2005. The article from the Journal of Proteome Research concluded that “The high abundance of oligosaccharides in the tear fluid of …

Rosacea News May 2012

1. Why Has No One Found a Cure for Rosacea?

Why has no one found something even remotely close to a cure for rosacea ? Why do researchers admit that they can barely even describe the disease ? Well a clue emerges from a recent series of in depth, state of the art papers from the Journal of Investigative Dermatology Symposium Proceedings. In the introductory item title  “Pathophysiology of Rosacea: Introduction”, Dr. Martin Steinhoff …

2. Scenesse Starts Phase III Trials for EPP in the US

News today that Scenesse has progressed another step towards wider approval with the commencement of Phase III Trials. About 100 people with the condition Erythropoietic Protoporphyria (EPP) will be double blinded to receive the Scenesse implant or placebo. …

3. Smokers Much Less Likely to get Rosacea

Yes you read correctly, some recent research conducted in the UK has found that smoking is associated with a substantially reduced risk of developing rosacea. The study …

4. How Much Would You Pay to Cure Your Rosacea?

Most published abstracts are a pretty dry read. This one is about as dry as they come. How about titling it “Rosacea Sufferers Willing To Pay Less than Vitiligo, …

5. Coblation with Saline and Radio Frequency Induced Plasma: Rhinophyma Miracle

The Daily Mail continues to show itself as the premier newspaper for rosacea related news stories. This last weekend the paper has a great …

6. Rosaliac AR Intense from La Roche-Posay

In 2010 La Roche Posay  took the opportunity of the rosacea awareness month and their support of the National Rosacea Society to promote their product – Rosaliac UV Fortifying Anti-Redness Moisturizer with SPF 15.

7. Novartis Buys Fougera for $1.5B, gets Generic Metrogel

News today that the giant pharmaceutical company Novartis International is buying Fougera Pharmaceuticals.

Fougera is known to rosacea sufferers through the availability of generic metronidazole 0.75%. Fougera will brings its specialty in generics to Sandoz, the generics division of Novartis.

Rosacea News January 2012

1. IPL Burns from Perth Home Operator

An article in this Weekend’s West Australian highlighting the dangers of IPL Treatments from untrained operators. This article is a reminder of the dangers of IPL in the wrong hands. Other warnings are, sadly, easy to find. Finding the right practitioner to treat you with IPL is not an easy task. This is a real dilemma for rosacea sufferers as we …

2. Taro Readying for Generic Metrogel 1%

A recently posted clinical trial suggests that Taro Pharmaceuticals is readying to gain approval to market Generic Metrogel 1%. Currently Generic Metrogel is only available in 0.75% strength. Taro Pharmaceuticals in fact already markets a generic form of Metrogel – Metronidazole Gel USP, 0.75% When the patent covering Metrogel 0.75% expired, Galderma changed the formulation, increased the concentration of metronidazole to 1% …

3. Patents Expire for Liptor and Zyprexa, Oracea Small Fry

While us in the rosacea world might consider products that are expensive while they are covered by exclusive patents, we are small fry in the drug market at large.

Patents are due to shortly expire for Pfizer’s Liptor and Lilly’s Zyprexa. Lilly can expect a $3bn drop in revenue just from generic forms  of Zyprexa becoming available. Pfizer is thought to have earned around $7.8bn from …

4. Metrogel 1% Pump; for those who don’t like a Tube?

Galderma have announced that Metrogel 1% will now be available in a 55gm Pump. Galderma are citing the benefits of a better looking dispenser, minimizing waste, easier compliance with prescribing instructions and “facilitating product handling”. Galderma received FDA …

5. 2011, The Year in Review

Happy New Year to everyone who reads Rosacea Support ! As we start 2012 lets look briefly at what was popular in the last year. …

Rosacea News February 2012

1. Treating Neurogenic Rosacea with ETS

Now that the collection of symptoms called Neurogenic Rosacea has become more widely known, new discussions can take place as, for example how to best treat it.

This recently published abstract details a patient who suffered debilitating facial redness and burning. The patient was treated with the invasive and possibly irreversible procedure Endoscopic Thoracic Sympathectomy. The patient had a good response to ETS.

2. Cyclosporin better than Artificial Tears for Ocular Rosacea

Skin and Allergy News has an article today highlighting the recent positive research into the usage of Cyclosporin as a treatment for Ocular Rosacea.

Dr. Harper mentions that she likes to include Oracea as an oral treatment for the worst of her ocular rosacea patients, but …

3. Get ready for Tinted Finacea

A recently surfaced patent assigned to Intendis suggests that we might soon see a Tinted Finacea reach the market.

According to the patent application, a tinted formulation of Finacea had improved anti-inflammatory effects compared to regular Finacea – “Surprisingly, it was found that there was a further marked reduction in cytokine release in the cultures treated with azelaic acid and titanium dioxide-coated potassium aluminium silicate 3%”.

4. Doxycycline can deactivate Cathelicidins

A recently published abstract from the house of Gallo suggests a clue as to how doxycycline might work in treating rosacea. The suggestion from this research is that doxycycline has a newly discovered mechanism of action whereby it is able to prevent the activation of cathelicidin.

Cathelicidin has been in the rosacea news since around 2002, gaining publicity because of the discoveries like the fact …

5. Maruho Acquires Cutanea Life Sciences

News this week that the Japanese company Maruho is to acquire Pennsylvania based Cutanea Life Sciences. Cutanea Life Sciences is developing Omiganan as a treatment for rosacea.
Maruho Co., Ltd. Acquires Cutanea Life Sciences, Inc.

6. Massive Rosacea Study (CD5024) Recruiting Underway

A large study looking at a treatment for the papules and pustules of rosacea is looking to recruit participants right across the US and Canada.

A web site just for this study has been created at www.pprstudy.com (Papulo – Pustular – Rosacea Study). On the site you can use your ZIP code to see if there is a study location close to you.

Rosacea News March 2012

1. Uriage Thermal Water for a Red Face (2012 AAD San Diego)

I have to admit that I had never heard of Uriage Thermal Water before reading this poster abstract. Best I can tell, Uriage Thermal Water is a mineral water sourced from the French Alps.  It “possesses an exceptionally high content of mineral salts and trace elements in comparison with thermal waters used in dermatology (i.e. 11,000 mg/l). These mineral salts and trace elements have …

2. La Roche-Posay and L’Oreal Sensitive Skin Research

Thought that the following Poster Session from the recent 2012 AAD Annual Meeting in San Diego was encouraging because we really do want to see new products being developed specifically for people with sensitive skin. La Roche Posay is one of the skincare brands owned by L’Oreal. La Roche Posay may be known to rosacea sufferers through the actually little-known Rosaliac UV …

3. Sansrosa Phase II Results at 2012 AAD San Diego

Some Phase II Trial results for Sansrosa were presented at the recent 2012 AAD Annual Meeting in San Diego. Joseph F. Fowler, M.D., Clinical Professor of Dermatology at the University of Louisville was the principal study investigator. A summary of these results was mentioned in October 2011 via a press release covered here: Sansrosa not Susceptible to Tolerance or Rebound Whilst …

4. Sulphur Still a Classic Treatment for Rosacea (2012 AAD San Diego)

The following Poster Session from the 2012 AAD meeting in San Diego aimed to raise the profile of the use of sulphur as a treatment in rosacea. Did you …

5. Frank C. Powell at 2012 AAD San Diego

If you were able to attend the 2012 annual meeting of the AAD in San Diego you would have been able to attend the following discussion group on Rosacea.  The director of the session, Prof. Powell is known to rosacea sufferers because of his excellent book Rosacea Diagnosis and Management. Powell has been a consultant dermatologist at the Mater Private Hospital in Dublin, …

6. Zinc Sulfate Doesn’t Work for Rosacea

Despite a 2006 study in a prestigious journal that showed some modest benefit from taking 100mg a day of Zinc Sufate, a more recent study with a …

7. Mysterious L’Oreal Lotion Good for Redness (2012 AAD San Diego)

At the recent AAD 2012 Annual Meeting in San Diego, a poster session sponsored by L’Oreal looked quite interesting. The session detailed some research on an un-named facial lotion. The research claimed a statistically significant improvement in redness after 4 weeks of use. No searching could find a product from L’Oreal that contained the following ingredients; palmitoyl tripeptide-8 …

8. Foamix Minocycline Foam works for Bacterial Infections

A recent press release teases rosacea sufferers that a topical foaming form of minocycline might become a new treatment. The trial results promoted in the press release are for a condition called Impetigo, …

9. Sansrosa Completes Phase III Trials

A short press release today from Galderma to say that the 2 Phase III trials for Sansrosa have completed successfully. These latest large scale trials were able to confirm the positive findings resulting from the Phase II trials. This must be a great relief to Galderma who had to return to Phase II trials after previously commencing Phase III trials. …

10. What about Acne in Children?

The following video from the American Acne & Rosacea Society will be interesting to those who are looking for more information about how to treat acne in children. Children require special attention when presenting with acne as some of the adult treatments may be unsuitable for children. The guidelines offer advice for adolescent acne, preadolescent acne, infantile and neonatal acne. …

11. Ziana Almost Works for Rosacea

In January 2009 we learnt that Medicis was interested in trialing Ziana as a treatment for rosacea. Medicis may be known to rosacea sufferers because they also make Plexion and Solodyn. Sadly the rigorous nature …

12. Avermectin Milbemycin Eyewash for Ocular Rosacea

This recently published patent is interesting for a couple of reasons. Firstly there is renewed interest in Ivermectin because of Galderma’s large trial of Topical Ivermectin 1% Cream (CD5024) for facial rosacea. Secondly there are few official treatments for ocular rosacea, so a provable treatment such as outlined in this patent could show promise. A word of caution is needed here of course. …

13. Azeloglicina (Azelaic Acid + Glycine) for the Redness of Rosacea

A newly published article introduces us to a new formulation of Azelaic Acid known as Azeloglicina. Azeloglicina (chemical name  Potassium Azeloyl Diglycinate) is described as a “condensation product between one mole of Azelaic Acid and two moles of Glycine” and is touted as an improvement over the individual properties of both. A company called Singerga holds the patent on Azeloglicina. …

Rosacea News April 2012

1. Demodex Bacteria Inhibits Corneal Wound Recovery

This just published abstract takes the demodex bacteria based irritation line of research a step further. Researchers in Ireland were able to show that demodex bacteria Bacillus oleronius proteins induced an “aberrant wound healing response” in  the cells irritated by scratch in a cornea. The aberration appeared as an elevated immune response and an chagnes in cells’ inability to move like normally …

2. Cetaphil DermaControl Oil Control Foam Wash and Moisturizer for Oily Skin

Cetaphil has launched 2 new products that are targeted at oily or acne-prone skin. The products are called, take a breath; Cetaphil DermaControl Oil Control Moisturiser SPF 30 and Cetaphil DermaControl Oil Control Foam Wash. The Oil Control Moisturizer is promoted as a lightweight 3-in-1 moisturizer for acne-prone skin. It is said to provide broad spectrum sun protection, control shine without over-drying. The SPF …

3. `My Naked Secret’ looking for Rosacea Sufferers

Live in the UK? Interesting in being a part in the My Naked Secret 2 series? The producers of this Channel 4 programme, who are based in London are looking …

4. Miranda from Sex and The City tells of her Rosacea

In a series of 6 videos, Cynthia Nixon who played Miranda in Sex and The City, talks about her battle with rosacea. The professionally produced videos point viewers to the …

5. Allergan Trialing Oxymetazoline for Facial Redness

A just-posted trial notification shows very early clinical trials by Allergan, for their product they have named AGN-199201. The double blind trial will compare 3 different formulations of AGN-199201 with with the vehicle. The decrease in redness …

6. Oracea Sales “Excellent”, Gaining Market Share

How much does Galderma earn each year from Oracea sales ? Well the actual amount is not published, but in September 2011 court proceedings we learnt that Mylan Pharmaceuticals projected sales of $260m in 2011 for Oracea. The parent company of Galderma, L’Oreal does not publish Oracea sales figures, so this press release is as close as you can find to something that …

7. “Medical Crowdsourcing” via CureTogether – the new cheap data collection method

A recent article in the Dermatology Online Journal introduced me to a new online support group site. Apparently curetogether.com is a major medical crowdsourcing site. What is crowdsourcing? Well crowdsourcing is a new buzzword which basically means to get your information from the “crowd” or as many people as you can. Online this term generally means something like “just asking everyone …

8. Oracea is Not an Antibiotic, Apparently

This claim from the Oracea web site caught my eye. Oracea is NOT an antibiotic. A bit of poetic marketing license perhaps?

Oracea is a 40mg dose of the antibiotic doxycycline, which is a member of the tetracycline family. 30mg of the dose of doxycycline is immediate release, and 10 mg is locked inside a coating that …

9. Theory: Ivermectin is Metrogel’s Cousin, Help Needed

OK, bear with me. I don’t often just waffle here as a Rosacea News item. Maybe I should. Anyway this post is just me exploring an idea. From my high school organic chemistry it seems to me that Ivermectin and Metrondizole are in fact chemically akin to cousins. I started to think about this because of the huge investment being undertaken by …

10. More Proof that CD5024 is Ivermectin

The mysterious CD5024 1% Cream for which Galderma is conducting a large Phase III trial, has further been confirmed as the anti-parasitic Ivermectin.

This latest confirmation comes from the World Heath Organisation’s International Clinical Trials Registry Platform Search Portal. The search for CD5024 reveals trials that have completed in the Czech Republic, Germany and Hungary. The register was created in 2006, the same year as when …

11. It would be hard to invent a more embarrassing disease than Rosacea

Thought this was a great line from a recent NRS Blog Posting: It would be hard to invent a more embarrassing disease than rosacea.  Nice. I’m sure many many rosacea sufferers would agree.

Cure and Banish Rosacea with junk ebooks

If you ever wanted to read Banish Rosacea by Robert Campbell then you don’t have to hand over any money just go to this link Rosacea Cure eBooks: All Just SPAM?. By the way, you won’t be surprised to learn that this spammy ebook wasn’t actually written by someone called Robert Campbell, it is just a made up name.

Also, there, you will find reviews of

• Rosacea, The Cure is in your kitchen by Ron Tramontano

• Cure Your Rosacea

• Autoimmune The Cause and Cure (Nature Had it First)

• Rosacea No More

• Rosacea Free Forever by Laura Taylor.

and a link to actually the book you should be buying.

Rosacea News December 2011

1. UV Exposure leads to Oxidative Stress

As researchers try to further describe exactly what is going on in rosacea, more tiny bits of information arise. Here, this abstract is telling us that; Ferritin positive cells are much more prevalent in rosacea sufferers Severe rosacea sufferers have significantly more ferritin positive cells Blood peroxide levels are higher in rosacea sufferers …

2. CD5024 Cream in Phase 3 Trials (Metrocream 1% ?)

Galderma has another rosacea-targeted treatment, until now undisclosed, in the final stages of approval. Hey – how come no one told me?

Could it be possible that the rosacea heavyweight Galderma has kept a new product so secret?
What is this CD5024?
Just what exactly is this CD5024 1% Cream? Galderma …

3. “Glaucoma Gel” Good for Redness: Daily Mail

The Daily Mail continues its interest in rosacea treatments with an article about an unnamed glaucoma treatment that has been formulated as a gel treatment for the redness of rosacea. Of course we know this treatment as Sansrosa. Other names we have seen over the years include COL-118 and CD07805/47. The active ingredient in the glaucoma treatment of mentioned …

4. Ocular Rosacea Video Worth a Watch

Thanks to a tip from Dori, on the Rosacea Support Group Email Group, here is a link to a video of a lecture giving a good overview of ocular rosacea and treatments.
Ocular Rosacea: Curse of the Celts and Celeb…

5. Finacea matches the pH of Skin so Penetrates Well

We know that the pH of skin is around 5.4. The makers of Finacea, Intendis have formulated Finacea to be pH of 4.8, which means that Finacea is reasonably close to the same pH as skin. One of …

6. IPL London Spa Burn Victim Awarded Tens of Thousands in Damages

In 2008 we heard about Charlotte Cripps, a writer for the The Independent was badly burned by an IPL treatment at a London Spa. Today we …

7. Treating Intestinal Bacteria with Xifaxan May Improve Rosacea

Some more recent publicity from Internal Medicine News on the possible link between Small Intestinal Bacteria Overgrowth (SIBO) and Rosacea. In 2008 Rosacea News highlighted a paper that suggested that treating patients with rosacea and SIBO with Rifaximin would improve both their SIBO and rosacea symptoms. That posting has attracted a lot of interest, heading towards 100 comments. Two threads …

8. Finacea Foam Trials Results Look Good

Some recent trial results confirm that Intendis are moving forward with the development of Finacea Foam. The summary of a recent trial, quoted in Skin and Allergy News shows that Finacea Foam is more effective at reducing rosacea symptoms compared to the inactive vehicle. This trial doesn’t show whether Finacea Foam is more effective than Finacea Gel, but does suggest that Finacea Foam likely to …

Rosacea News December 2011

1. UV Exposure leads to Oxidative Stress

As researchers try to further describe exactly what is going on in rosacea, more tiny bits of information arise. Here, this abstract is telling us that; Ferritin positive cells are much more prevalent in rosacea sufferers Severe rosacea sufferers have significantly more ferritin positive cells Blood peroxide levels are higher in rosacea sufferers …

2. CD5024 Cream in Phase 3 Trials (Metrocream 1% ?)

Galderma has another rosacea-targeted treatment, until now undisclosed, in the final stages of approval. Hey – how come no one told me?

Could it be possible that the rosacea heavyweight Galderma has kept a new product so secret?
What is this CD5024?
Just what exactly is this CD5024 1% Cream? Galderma …

3. “Glaucoma Gel” Good for Redness: Daily Mail

The Daily Mail continues its interest in rosacea treatments with an article about an unnamed glaucoma treatment that has been formulated as a gel treatment for the redness of rosacea. Of course we know this treatment as Sansrosa. Other names we have seen over the years include COL-118 and CD07805/47. The active ingredient in the glaucoma treatment of mentioned …

4. Ocular Rosacea Video Worth a Watch

Thanks to a tip from Dori, on the Rosacea Support Group Email Group, here is a link to a video of a lecture giving a good overview of ocular rosacea and treatments.
Ocular Rosacea: Curse of the Celts and Celeb…

5. Finacea matches the pH of Skin so Penetrates Well

We know that the pH of skin is around 5.4. The makers of Finacea, Intendis have formulated Finacea to be pH of 4.8, which means that Finacea is reasonably close to the same pH as skin. One of …

6. IPL London Spa Burn Victim Awarded Tens of Thousands in Damages

In 2008 we heard about Charlotte Cripps, a writer for the The Independent was badly burned by an IPL treatment at a London Spa. Today we …

7. Treating Intestinal Bacteria with Xifaxan May Improve Rosacea

December 6th, 2011, by David Pascoe | diet, rosacea cause | Edit

Some more recent publicity from Internal Medicine News on the possible link between Small Intestinal Bacteria Overgrowth (SIBO) and Rosacea. In 2008 Rosacea News highlighted a paper that suggested that treating patients with rosacea and SIBO with Rifaximin would improve both their SIBO and rosacea symptoms. That posting has attracted a lot of interest, heading towards 100 comments. Two threads …

8. Finacea Foam Trials Results Look Good

Some recent trial results confirm that Intendis are moving forward with the development of Finacea Foam. The summary of a recent trial, quoted in Skin and Allergy News shows that Finacea Foam is more effective at reducing rosacea symptoms compared to the inactive vehicle. This trial doesn’t show whether Finacea Foam is more effective than Finacea Gel, but does suggest that Finacea Foam likely to …

Rosacea News October 2011

Better late than never …

1. Demodex Infestation: the Missing Link ?

Firmly in the pure speculation category is a recent paper that proposes that pityriasis folliculorum (or demodex mite infestation) is the missing link in our understanding of rosacea. Plainly put, Dr. Forton, a dermatologist from Belgium, suggests that rosacea is a …

2. NRS highlights Neurologic form of Rosacea

The NRS Blog today mentions the recent publications that raise a possible new Subset of Rosacea. Even though this is just a passing reference, it is good to see that the NRS …

3. Elorac Patenting Oral Niacinamide + Oral Azelaic Acid (Finacea)

An unusual patent has surfaced that is suggesting the oral use of azelaic acid. Azelaic Acid is better known as the active ingredient in the topical finacea. This patent suggests an oral treatment that combines niacinamide with azelaic acid. The owner of the patent, Elorac is known from their recent trials of Carbamide Peroxide as a rosacea treatment. Finacea has received some …

4. Sansrosa not Susceptible to Tolerance or Rebound

Some news today from the Phase 2B Sansrosa Trials;

Galderma is now confirming that during the 8 week trial, participants did not suffer from tachyphylaxis or rebound.

This means that if you stop and start sanrosa or continue to use it for an extended period you likely won’t suffer from a rebound effect or from a reduced effectiveness.

This is some good news as it indicates the formulation …

5. Merck Trialling Laropiprant for the Redness of Rosacea

A product from Merck designated as MK-0524, also known as Laropiprant, is to be trialled as a treatment for the redness of rosacea. This is great news for rosacea …

6. Get ready for MetroFoam

A recently updated patent application by Galderma shows that they want to reserve the right to create a Metronidazole Foam product.

Galderma has a long history with topical metronidazole products, starting with Metrogel 0.75%, then adding Metrolotion and Metrocream, and when the patent on the 0.7% Metrogel expired, Galderma created Metrogel 1%.

Past research seems to suggest that it matters little whether you use Metrogel, Metrolotion, …

7. Niacin Flushes More when we are Worried About What Others Think

Continuing his research in facial flushing and anxiety, Dr. Peter Drummond from Murdoch University has published  some new research on social anxiety and facial flushing.

The trial found that Niacin, which is known to induce a facial flush, actually causes more flushing in people that worry about what others think of them.

By blinding participants to whether they were given Niacin or placebo, and measuring facial blood …

8. Powell: Randomized Clinical Trials are not the whole story

Writing in the British Journal of Dermatology, the well known Rosacea Researcher Professor Frank Powell says that research based on randomized clinical trials are not the be-all and end-all for rosacea research. He tells us that there is still room for other sorts of innovation, especially when seeking treatments from your dermatologist. Recently a Cochrane review of 58 clinical trials told us that …

9. Obagi Rosaclear may be better than Metrogel 0.75% + Standard Skincare

Another published abstract that appears to be building the case for the Rosaclear Integrated Rosacea Treatment from Obagi. Although the article …

10. News Shorts: Internet Anxiety, Food Hospital

Some quick links to items from around the web. 1. Internet Searching leads to greater anxiety for melanoma sufferers Of course everyone is now using the internet to read up on everything health related. You may be headed for some unnecessary anxiety though, so be careful. Internet Use and Anxiety in People with Melanoma and Nonmelanoma Skin Cancer …